Du är här

2016-02-22

DSM N.V. : DSM announces repurchase of shares to cover existing option plans and stock dividend

Royal DSM, a global science-based company active in health, nutrition and
materials, today announces

that it intends to repurchase 3,200,000 ordinary shares, starting on 22
February 2016, in order to cover its commitments under existing management
and personnel option plans (2,500,000) and shares for stock dividend as part
of the final dividend 2015 (700,000). Based on the closing price of the DSM
share on Euronext Amsterdam on 19 February 2016 this would be equivalent to
approximately
€140
million.

DSM has signed a Discretionary Management Agreement with the bank that will
execute the repurchase. The repurchase price will be based on the daily VWAP
(Volume Weighted Average Price). Volumes to be repurchased will be on average
5% of the daily trading volume on the open market, within a bandwidth of 2-8%
per day. This share repurchase program is anticipated to continue into Q2
2016. The total number of shares to be repurchased under this program
represents approximately 1.76% of ordinary shares issued.

In accordance with regulations DSM will inform the market about the progress
made in the execution of this program through weekly press releases.

Statement pursuant to art. 5:25a of the Dutch Financial Supervision Act

DSM also announces that The Netherlands is its "Home Member State", as
required by article 5:25a (2) of the Dutch Financial Supervision Act. This
article obliges all listed companies to publicly announce which country is
their "home member state" (as referred to in article 5:25a(1) sub c of the
Dutch Financial Supervision Act) for purposes of regulation of their
disclosure obligations under the EU Transparency Directive. Pursuant to
section 5:25a of the Dutch Financial Supervision Act Royal DSM has notified
the Autoriteit Financiële Markten (AFM).

DSM - Bright Science. Brighter Living.(TM)

Royal DSM is a global science-based company active in health, nutrition and
materials. By connecting its unique competences in life sciences and
materials sciences DSM is driving economic prosperity, environmental progress
and social advances to create sustainable value for all stakeholders
simultaneously. DSM delivers innovative solutions that nourish, protect and
improve performance in global markets such as food and dietary supplements,
personal care, feed, medical devices, automotive, paints, electrical and
electronics, life protection, alternative energy and bio-based materials. DSM
and its associated companies deliver annual net sales of about €10 billion
with approximately 25,000 employees. The company is listed on Euronext
Amsterdam. More information can be found atwww.dsm.com.

For more information:

---------------------------------------------------------------------------------
| DSM Corporate CommunicationsHerman Betten DSM Investor RelationsDave Huizing |
|tel. +31 (0) 45 5782017 |
|e-mailmedia.contacts@dsm.com tel. +31 (0) 45 5782864 |
| e-mailinvestor.relations@dsm.com |
---------------------------------------------------------------------------------

Press Release-pdf
http://hugin.info/130663/R/1987928/729803.pdf

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: DSM N.V. via Globenewswire

HUG#1987928

Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.